Wells Fargo’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,400
| Closed | -$30K | – | 6767 |
|
|
2018
Q2 | $30K | Buy |
3,400
+500
| +17% | +$4.5K | ﹤0.01% | 5737 |
|
|
2018
Q1 | $29K | Sell |
2,900
-55,951
| -95% | -$470K | ﹤0.01% | 5728 |
|
|
2017
Q4 | $285K | Sell |
58,851
-25,500
| -30% | -$124K | ﹤0.01% | 4783 |
|
|
2017
Q3 | $384K | Sell |
84,351
-6,950
| -8% | -$32.6K | ﹤0.01% | 4508 |
|
|
2017
Q2 | $461K | Sell |
91,301
-34,935
| -28% | -$156K | ﹤0.01% | 4271 |
|
|
2017
Q1 | $600K | Sell |
126,236
-20,950
| -14% | -$106K | ﹤0.01% | 4120 |
|
|
2016
Q4 | $824K | Buy |
147,186
+1,600
| +1% | +$8.78K | ﹤0.01% | 3834 |
|
|
2016
Q3 | $808K | Buy |
145,586
+30,286
| +26% | +$200K | ﹤0.01% | 3635 |
|
|
2016
Q2 | $808K | Sell |
115,300
-6,150
| -5% | -$43.3K | ﹤0.01% | 3623 |
|
|
2016
Q1 | $803K | Buy |
121,450
+9,400
| +8% | +$69.2K | ﹤0.01% | 3547 |
|
|
2015
Q4 | $1.15M | Sell |
112,050
-4,100
| -4% | -$47.5K | ﹤0.01% | 3391 |
|
|
2015
Q3 | $1.37M | Sell |
116,150
-6,100
| -5% | -$67.4K | ﹤0.01% | 3280 |
|
|
2015
Q2 | $1.12M | Buy |
122,250
+11,415
| +10% | +$86.2K | ﹤0.01% | 3513 |
|
|
2015
Q1 | $688K | Buy |
110,835
+9,725
| +10% | +$60.2K | ﹤0.01% | 3759 |
|
|
2014
Q4 | $566K | Buy |
101,110
+9,550
| +10% | +$55.6K | ﹤0.01% | 3883 |
|
|
2014
Q3 | $539K | Sell |
91,560
-5,122
| -5% | -$31.2K | ﹤0.01% | 3854 |
|
|
2014
Q2 | $662K | Buy |
96,682
+22
| +0% | +$147 | ﹤0.01% | 3780 |
|
|
2014
Q1 | $697K | Buy |
96,660
+14,200
| +17% | +$98.1K | ﹤0.01% | 3708 |
|
|
2013
Q4 | $545K | Buy |
82,460
+55,858
| +210% | +$380K | ﹤0.01% | 3761 |
|
|
2013
Q3 | $193K | Buy |
+26,602
| New | +$179K | ﹤0.01% | 4218 |
|
Wells Fargo's JNP Position: Q3 2018 in Review
Wells Fargo sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 3,400 shares — an estimated $30K sold.
Wells Fargo first reported a position in JNP in Q3 2013 and held it in 20 quarters. The position peaked at $1.37M in Q3 2015. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Wells Fargo reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Wells Fargo sold 3,400 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $30K.
- Wells Fargo first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 20 quarters.
- Wells Fargo's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.37M in Q3 2015.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Wells Fargo's 13F filing for Q3 2018, filed 2 Nov 2018.